LENZ Therapeutics (LENZ) Other Accumulated Expenses (2020 - 2023)
LENZ Therapeutics (LENZ) reported Other Accumulated Expenses of $143000.0 for Q4 2023, down 89.44% year-over-year from $1.4 million in Q4 2022, and down 35.29% on a QoQ basis from $221000.0 in Q3 2023.
LENZ Therapeutics (LENZ) has 4 years of Other Accumulated Expenses data on file, last reported at $143000.0 in Q4 2023.
- Quarterly Other Accumulated Expenses fell 89.44% year-over-year to $143000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $143000.0 (down 89.44% YoY) and the FY2023 annual result came in at $143000.0, down 89.44% from the prior year.
- Other Accumulated Expenses fell to $143000.0 in Q4 2023 per LENZ's latest filing, from $221000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $4.9 million in Q1 2023 and bottomed at $71000.0 in Q4 2020.
- The 4-year median for Other Accumulated Expenses is $420500.0 (2021), against an average of $1.0 million.
- Peak annual rise in Other Accumulated Expenses reached 1611.17% in 2023, while the deepest fall reached 89.44% in 2023.
- Tracing LENZ's Other Accumulated Expenses over 4 years: stood at $71000.0 in 2020, then jumped by 411.27% to $363000.0 in 2021, then surged by 273.0% to $1.4 million in 2022, then tumbled by 89.44% to $143000.0 in 2023.
- Per Business Quant, the three latest LENZ Other Accumulated Expenses figures stand at $143000.0 (Q4 2023), $221000.0 (Q3 2023), and $3.1 million (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | LENZ Therapeutics | 235.77 Mn | 235.77 Mn | 825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 143,000.00 |
| Sep 30, 2023 | 221,000.00 |
| Jun 30, 2023 | 3.06 Mn |
| Mar 31, 2023 | 4.89 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Sep 30, 2022 | 478,000.00 |
| Jun 30, 2022 | 179,000.00 |
| Mar 31, 2022 | 872,000.00 |
| Dec 31, 2021 | 363,000.00 |
| Sep 30, 2021 | 509,000.00 |
| Jun 30, 2021 | 227,000.00 |
| Dec 31, 2020 | 71,000.00 |